chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Her heart rate went to 120 or 130 for about 24 hours; Chest pain/Chest achiness; Chest discomfort; What feels like a cool breeze internally in her chest; chills; nausea; headache; This spontaneous case was reported by a nurse and describes the occurrence of HEART RATE INCREASED (Her heart rate went to 120 or 130 for about 24 hours), CHEST PAIN (Chest pain/Chest achiness), CHEST DISCOMFORT (Chest discomfort), FEELING COLD (What feels like a cool breeze internally in her chest) and CHILLS (chills) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Hashimoto's thyroiditis.   On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 03-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced HEART RATE INCREASED (Her heart rate went to 120 or 130 for about 24 hours), CHEST PAIN (Chest pain/Chest achiness), CHEST DISCOMFORT (Chest discomfort), FEELING COLD (What feels like a cool breeze internally in her chest), CHILLS (chills), NAUSEA (nausea) and HEADACHE (headache). At the time of the report, HEART RATE INCREASED (Her heart rate went to 120 or 130 for about 24 hours) had resolved, CHEST PAIN (Chest pain/Chest achiness), CHEST DISCOMFORT (Chest discomfort) and FEELING COLD (What feels like a cool breeze internally in her chest) had not resolved and CHILLS (chills), NAUSEA (nausea) and HEADACHE (headache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In December 2021, Heart rate: 120 to 130 (High) Heart rate went to 120 to 130 for about 24 hours..     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment medications were reported. The heart rate and rhythm were normal afterwards. The patient also informed that on 13-Dec-2019 after being on vacation, the patient ended up in the hospital with flu like symptoms, pneumonia, thyroid toxicosis, & an elevated heart rate of 100 to 120.   This case was linked to MOD-2021-406603, MOD-2021-406622, MOD-2021-406763 (Patient Link).
1/2 dollar size welts - bad aching all over, 100.3 temp. 168/ blood pressure norm 120/ 100 heart beat. 10-29-12 had shot didn't feel normal until 11/6. Couldn't do anything strenuous without rapid heart beat until 11-5-2012. Seven large welts, one with inch wide to my armpit.
CHILD DEVELOPED FEVER OF 101 ON 12/07/2006. ON 12/08/2006 FEVER WAS UP TO 104 -105, PEAKING AT 105.3, ON THAT DAY HE ALSO DEVELOPED RASH AND MOTHER STATES HE SEEMS DEHYDRATED. WAS TAKEN TO MD WHERE HE SEIZURED SEVERAL TIMES. TAKEN TO EMERGENCY ROOM WHERE BLOOD TESTS WERE DONE TO RULE OUT BACTERIAL OR VIRAL INFECTIONS. TALKED TO MOTHER ON 12/11/2006 STILL FEBRILE (LOW GRADE) AND LETHARGIC. TALKED TO MOTHER AGAIN ON 12/15/2006, SHE STATES HE IS BACK TO NORMAL, NO FURTHER SEIZURE ACTIVITY.
Mother presented in office 1/27/2005 two days after her son received his Dtap booster. His left deltoid was red swollen and warm to touch. Mother states that she made an appointment for him to see his MD but he can't get in until tomorrow. Mother states that she used a cool compress on his arm yesterday. Instructed to continue the cool compress. Also instructed to give Benadryl elixir until he can get into MD.
Fussy and slept after shots, slept. Felt very warm - T 104 under arm. Gave TYLENOL - brought it down about 101 - 102. Fever lasted 2-3 days-no other symptoms. Redness/swelling on leg(doesn't remember which one).
After shot gradual onset of weakness, dizziness (patient reports feeling "off") continued to get worse. In the evening patient's reported her neck and chest became red with a rash and her pulse was very high (124bpm & 221bpm reported by patient). Patient went to the Emergency Room to be seen and treated.
Patient, mom and pharmacist miscommunicated age.  Need to know how to proceed with second dose
Information has been received from a physician concerning a 15-month-old female with Down's Syndrome who in the end of January 2007 or the beginning of February, was vaccinated with ProQuad. The patient experienced rash within 1 week of vaccination. Unspecified medical attention was sought. No laboratory or diagnostic testing was performed. The outcome was reported as recovered. There was no product quality complaint involved. No additional information to report. Follow up information indicated that no additional information could be provided. No additional information is expected.
expired dose of adacel was administered with no reported adverse event; Initial information received on 17-Oct-2022 regarding an unsolicited valid  non-serious case received from a other health professional.  This case involves a 12 years old female patient who had expired dose of adacel was administered with no reported adverse event while receiving vaccine DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE [ADACEL].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included INFLUENZA VACCINE INACT SPLIT 4V (FLUZONE QUADRIVALENT); HPV VACCINE VLP RL1 4V (YEAST) (GARDASIL); and MENINGOCOCCAL VACCINE A/C/Y/W CONJ (TET TOX) (MENQUADFI).  On 17-Oct-2022, the patient received 0.5 mL total dose of suspect DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE once (formulation and strength not reported; lot C5788CA and expiry date: 14-Oct-2022) via intramuscular route in the left arm for prophylactic vaccination.  On 17-Oct-2022, (latency: same day) the patient had expired dose of adacel was administered with no reported adverse event (expired product administered) following the administration of DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE.  Action taken with DIPHTHERIA, TETANUS AND ACELLULAR PERTUSSIS VACCINE (ADACEL) was not applicable.  At time of reporting, the outcome was Unknown for the event.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Vaccine administered to patient under 18; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Vaccine administered to patient under 18) in a 15-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 28-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-May-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Vaccine administered to patient under 18). On 28-May-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Vaccine administered to patient under 18) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.  Treatment information was not provided.
Redness and warmth distal to the injection site. Slight bruising at the site, tender to touch, entire upper arm. No fever c/o some muscles aches and HA.
Vertigo; This spontaneous case was reported by a consumer and describes the occurrence of VERTIGO (Vertigo) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VERTIGO (Vertigo). At the time of the report, VERTIGO (Vertigo) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were not reported.  Treatment details not provided.  Patient informed that a lot of people online have been reporting vertigo after receiving the vaccine
Itching, swelling with blanchable erythema, and localized warmer skin near site of injection with a downward spread w/o signs of acute allergic reaction.
Pt received 4th dose of Anthrax. Pt left clinic asymptomatic return 15 min later accompany by supervisor c/o coughing, SOB, and difficulty breathing. Rapid Response team was initiate. Start O2 Non-rebreather mask 15LPM and 2 puffs albuterol inhaler. Pt was seen in clinic by her Primary Care physician and released.
patient developed a large bruise that starts about 3 inches below the injection site and is roughly 3 inches by 3 inches in size. bruise is yellow and purple colored. there is one smaller bruise that is about  a half inch from the injection site and about the size of a quarter. Her arm is achy but not severe. She is not on blood thinners and did not bump her arm lately.  There is no mark at the injection site. I administered the vaccine and do not believe she bled more than a pin point at time of vaccination. no other complaints at this time.
Roughly an hour after started getting numb feeling in the roof of my mouth. Feeling went away rather soon but was back by around 9 am the next morning. Over the course of six hours the feeling was moving into the tongue and back of throat. Throat and mouth started hurting as well.Stopped being able to swallow properly. Was given Benadryl and a steroid at urgent care and have not had any more swelling over the past two days.
Heaviness on the chest; Chest pain; Pain in the injection site; sleepy; Lethargic; This spontaneous case was reported by a consumer and describes the occurrence of CHEST DISCOMFORT (Heaviness on the chest), SOMNOLENCE (sleepy), LETHARGY (Lethargic), CHEST PAIN (Chest pain) and VACCINATION SITE PAIN (Pain in the injection site) in a 47-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036B21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included LEVOTHYROXINE for an unknown indication.    On 06-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Apr-2021, the patient experienced SOMNOLENCE (sleepy), LETHARGY (Lethargic) and VACCINATION SITE PAIN (Pain in the injection site). On 12-Apr-2021, the patient experienced CHEST DISCOMFORT (Heaviness on the chest) and CHEST PAIN (Chest pain). On 09-Apr-2021, VACCINATION SITE PAIN (Pain in the injection site) had resolved. On 10-Apr-2021, SOMNOLENCE (sleepy) and LETHARGY (Lethargic) had resolved. On 23-Apr-2021, CHEST DISCOMFORT (Heaviness on the chest) and CHEST PAIN (Chest pain) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient did not take medication to treat symptoms but fasted for 12 hours a couple of days and felt better.   Most recent FOLLOW-UP information incorporated above includes: On 28-May-2021: Follow up received on 28-May-2021 and contains non significant information.
The patient was directed to redo her varicella and HepB series after blood tests for medical school showed a non-response to the first series. A week after the injections, the patient woke up with a numb lower left leg. Three days after, the patient tried to get out of bed and collapsed, unable to support her own weight. In the ER that day a lumbar puncture was performed for suspected Guillain-Barre. After being admitted to the hospital the next day, other tests were run to rule out anything other than Guillain-Barre. She was first given 5 treatments of intravenous immunoglobulins, and showed little response. She then underwent five plasma exchange treatments. The first hospital stay lasted three weeks, and then the patient was discharged to a physical rehabilitation hospital. After showing little improvement there for a week, she was re-admitted to the hospital because her weakness was worsening and underwent plasma exchange again. After two and a half more weeks in rehab, she was readmitted to the hospital due to more weakness and received 5 treatments of IVIG. She then completed two weeks of further rehab and was discharged to a day treatment therapy program three days a week.
sluggish; Body aches; fatigue; fever; This spontaneous case was reported by a patient and describes the occurrence of SLUGGISHNESS (sluggish), MYALGIA (Body aches), FATIGUE (fatigue) and PYREXIA (fever) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 038B21A and 001B21A) for COVID-19 vaccination.     Concurrent medical conditions included Pollen allergy (Reaction- Sneezing, watery eyes.) since 1970, Allergic reaction to antibiotics (Rash) since 2005, Allergic reaction to bee sting (cellulitis) since August 2010, Allergy to molds (Reaction- Sneezing, watery eyes.) since 1970 and Seasonal allergy (Reaction- Sneezing, watery eyes.) since 1970. Concomitant products included MULTIVITAMIN [VITAMINS NOS], COLECALCIFEROL (D3), FISH OIL (OMEGA 3 [FISH OIL]), VACCINIUM MACROCARPON (CRANBERRY EXTRACT [VACCINIUM MACROCARPON]) and CURCUMA LONGA (TURMERIC [CURCUMA LONGA]) for an unknown indication.   On 13-Mar-2021 at 11:15 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Apr-2021 at 11:15 AM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 10-Apr-2021, the patient experienced SLUGGISHNESS (sluggish), MYALGIA (Body aches), FATIGUE (fatigue) and PYREXIA (fever). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. On 11-Apr-2021, MYALGIA (Body aches) and PYREXIA (fever) had resolved. On 12-Apr-2021, SLUGGISHNESS (sluggish) and FATIGUE (fatigue) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In April 2021, Body temperature: 102 (High) High.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-062244 (Patient Link).
63 yo female patient complaining of a "tightness in her throat" Pt states she had multiple allergies. Pt given benadryl. No swelling to mouth or tongue noted. Pt denies any shortness of breath. Vital signs wnl. Pt stated she would sit and wait for awhile to see if she began feeling better. Pt advised she did not want to go to the hospital.
This spontaneous report as received from a licensed practical nurse refers to a patient of unknown age and unknown gender. The patient pertinent medical history was not reported. On 28-MAR-2014, the patient was vaccinated with ZOSTAVAX (dose strength and route was not reported) (lot # J011828 and expiry date: 26-DEC-2014, reported as 16-DEC-2015) which was improperly stored. Primary reporter was reporting excursion of 6 F since 01-JUN-2013 (confirmed date) affecting ZOSTAVAX, nurse also reported that products were not stored in an overall average support range of -58 degree F and 5 degree F. No adverse effects reported. No product quality complaint (PQC) was reported for ZOSTAVAX. This is one of the several reports from the same reporter. Additional information has been requested.
Patient fainted from a seated position approximately 10 to 15 minutes post vaccination. The patient hit the ground and regained consciousness. He was alert to time, date, and place. Ambulance was called, the blood glucose and blood pressure were within normal ranges.
Covid-19 vaccines reported to VAERS  due to temperature excursion.  VAERS report number Unknown /TSC.
PAIN, SWOLLEN, RING OF INFLAMMATION,  PURPLE KNOT AT INJECTION SITE.  WENT TO ER 2/27 WITH TEMP OF 101.54.   CHEST XRAY, BLOOD WORK, UNINALYSIS,.  IV FLUIDS, IV ANTIBIOTIC, ZOFRAN FOR VOMITING.  MD CONCLUDED REACTIN TO VACCINE.  FILL RX FOR ZOFRAN LATER THAT EVENING
INJECTION SITE ITCHING; INJECTION SITE SWELLING; INJECTION SITE REDNESS; SHOOTING PAIN IN ARM; LOW GRADE FEVER; INJECTION SITE HARD LUMP; INJECTION SITE TENDERNESS; TThis spontaneous report received from a patient concerned a female of unspecified age. The patient's height, and weight were not reported. The patient's concurrent conditions included asthma. The patient was not pregnant at the time of reporting. The patient experienced drug allergy when treated with methylprednisolone. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805031, expiry: UNKNOWN) dose was not reported, administered on 19-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On MAR-2021, the subject experienced injection site hard lump. On MAR-2021, the subject experienced injection site tenderness. On 19-MAR-2021, the subject experienced shooting pain in arm. On 19-MAR-2021, the subject experienced low grade fever. On 21-MAR-2021, the subject experienced injection site itching. On 21-MAR-2021, the subject experienced injection site swelling. On 21-MAR-2021, the subject experienced injection site redness.  Treatment medications included: diphenhydramine hydrochloride, ibuprofen, and paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from injection site itching on 2021, and shooting pain in arm, and low grade fever on 21-MAR-2021, was recovering from injection site swelling, had not recovered from injection site tenderness, and injection site hard lump, and the outcome of injection site redness was not reported. This report was non-serious.
Instant pain from shot, within 1hr extreme pain on entire left arm for about an hour. Tired, sore on left arm. Constant dull pain for a month. Pain when using deltoid muscle, got better, then progressively got worse again.
Information has been received from a physician concerning a patient who was vaccinated with a dose of ROTATEQ vaccine live (human-bovine) (no lot numbers available). Subsequently the patient experienced diarrhea. Medical attention was sought at the physician's office. As a result, the parents of the patient requested the ROTATEQ vaccine live (human-bovine) series not to be continued. It was noted that by the physician that a "couple of patients out of hundred doses" at the office have experienced diarrhea. The recovery status was unknown. There was no product quality complaint. This is one of several reports from the same source. Additional information has been requested.
I had fatigue for several day. I started getting pain in my stomach that is ongoing. On July 30th, to see the doctor. He set up an endoscopy, nothing found. They also found that I had a heart morrow, So, he set up on Echogram on Sept 8th. I also have an appointment with the cardiologist on the Nov. 29th.
no adverse event; a patient received a expired VAQTA; Information has been received from a registered nurse referring to a 58-year-old patient. The patient's pertinent medical history, concurrent condition and concomitant therapy were not reported.        On 27-AUG-2019, the patient was vaccinated with an expired hepatitis a vaccine, inactivated (VAQTA) (strength: 50 U/1.0 mL, lot # R027987, expiration date: 09-AUG-2019) for prophylaxis. No adverse effects reported.
p/vax pt later devel cold sweats, nausea, loss of appetite;6hr later vertigo;20hr later occasionally vertigo;flu synd stopped 72hr later;no vomiting or diarrhea;
No adverse event; Moderna vaccine (more or less 170 monovalent and 20 bivalent) which were beyond the 30 day beyond use date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 monovalent and 20 bivalent) which were beyond the 30 day beyond use date) and NO ADVERSE EVENT (No adverse event) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 939902) for COVID-19 prophylaxis.     No Medical History information was reported.    On 29-Sep-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Sep-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 monovalent and 20 bivalent) which were beyond the 30 day beyond use date). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 monovalent and 20 bivalent) which were beyond the 30 day beyond use date) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 monovalent and 20 bivalent) which were beyond the 30 day beyond use date).    No concomitant medication were reported.  Pharmacist reports that they have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 monovalent and 20 bivalent) which were beyond the 30 day beyond use date.  The BUD for lot number 939902 was reported as 02-Sep-2021. No treatment information was provided by the reporter.   This case was linked to US-MODERNATX, INC.-MOD-2023-704416 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Live follow up received with Updated narrative.; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-704416:Master case
This spontaneous report as received from a certified medical assistant refers to unspecified number of patients of unknown age and gender. The patients' medical history, concurrent conditions and concomitant medications were not reported. Since 22-AUG-2016, the patients were vaccinated with the doses of improperly stored GARDASIL 9 (lot # M009378, expiration date 23-APR-2018; dose and route were not reported). The vaccines were stored in 35.8 F for one hour and 15 minutes. All the vaccines were supported. No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
10-18-10 Evening - had fever, unk. degree. C/o pain 10-19-10 Mom noticed redness, swelling, heat & pt. c/o pain in (R) arm. Mom gave pt. TYLENOL on Tuesday.
Flare-up of shingles: pain along upper back, left side to left shoulder, rash upper left pec to shoulder. This is the same area I had the shingles when I was 18 in 1971. Treatment: Hydrocortisone  cream applying daily to affected area. Just started treatment today.
SOB - wheezing nausea, vomiting - Anaphylaxis treatment Epinephrine, Tylenol, Duoneb, Decadron, Benadryl, Pepsid Nss
PT recd 3 vaxs (1cc, IM del) 4OCT90, 15NOV90, & 11JUN91; w/in 24hr p/inject PT devd edema in (?rt) del & pain in arm radiating toward hand; edema was 4" in diameter & .5" thick & had continued thru 20JUN91; rx: Advil (1QID) & cold packs;